PC-TP/StARD2: Of membranes and metabolism

Trends in Endocrinology and Metabolism

Volumn 21, Issue 7, 2010, Pages 449-456

  Kang, Hye Won ^a   Wei, Jie ^a   Cohen, David E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; FATTY ACID; LECITHIN TRANSFER PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROIDOGENIC ACUTE REGULATORY PROTEIN; THIOL ESTER HYDROLASE; UNCLASSIFIED DRUG; ACOT13 PROTEIN, MOUSE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID TRANSFER PROTEIN;

BINDING SITE; BROWN ADIPOSE TISSUE; CELL STRUCTURE; CHOLESTEROL LIVER LEVEL; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; IN VITRO STUDY; LIPID METABOLISM; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW; THERMOGENESIS; ANIMAL; CELL MEMBRANE; HUMAN; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE, BROWN; ANIMALS; CELL MEMBRANE; FATTY ACIDS; HUMANS; MITOCHONDRIA; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID TRANSFER PROTEINS; PPAR ALPHA; THERMOGENESIS; THIOLESTER HYDROLASES;

EID: 77954309627     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.02.001     Document Type: Review

References (71)

1. Small D.M. The Physical Chemistry of Lipids. From Alkanes to Phospholipids 1986, Plenum Press.
2. White D.A. The phospholipid composition of mammalian tissues. Form and Function of Phospholipids 1973, 441-482. Elsevier. 2nd edn. G.B. Ansel (Ed.).
3. Schachter D. The hepatocyte plasma membrane: organization and differentiation. The Liver: Biology and Pathobiology 1994, 145-154. Raven Press. Third Edition. I.M. Arias (Ed.).
4. Smith R., Tanford C. The critical micelle concentration of L-α-dipalmitoylphosphatidylcholine in water and water-methanol solutions. J. Mol. Biol. 1972, 67:75-83.
5. Jiang X.C. The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis. Front. Biosci. 2002, 7:d1634-1641.
6. Jiang X.C., et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 2001, 7:847-852.
7. Rao R., et al. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry 1997, 36:3645-3653.
8. Cockcroft S., Carvou N. Biochemical and biological functions of class I phosphatidylinositol transfer proteins. Biochim. Biophys. Acta 2007, 1771:677-691.
9. Wirtz K.W. Phospholipid transfer proteins in perspective. FEBS Lett. 2006, 580:5436-5441.
10. Schroeder F., et al. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim. Biophys. Acta 2007, 1771:700-718.
11. Wirtz K.W. Phospholipid transfer proteins. Annu. Rev. Biochem. 1991, 60:73-99.
12. Geijtenbeek T.B.H., et al. cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene. Biochem. J. 1996, 316:49-55.
13. Cohen D.E., et al. Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein. Biochim. Biophys. Acta 1999, 1447:265-270.
14. Kanno K., et al. Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2. Biochim. Biophys. Acta 2007, 1771:654-662.
15. Kang H.W., et al. Mice lacking phosphatidylcholine transfer protein/StarD2 exhibit increased adaptive thermogenesis and enlarged mitochondria in brown adipose tissue. J. Lipid Res. 2009, 50:2212-2221.
16. Scapa E.F., et al. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 2008, 22:2579-2590.
17. Iyer L.M., et al. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins 2001, 43:134-144.
18. Ponting C.P., Aravind L. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem. Sci. 1999, 24:130-132.
19. Schrick K., et al. START lipid/sterol-binding domains are amplified in plants and are predominantly associated with homeodomain transcription factors. Genome Biol. 2004, 5:R41.
20. Soccio R.E., et al. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6943-6948.
21. Soccio R.E., Breslow J.L. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J. Biol. Chem. 2003, 278:22183-22186.
22. Alpy F., Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 2005, 118:2791-2801.
23. Tsujishita Y., Hurley J.H. Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 2000, 7:408-414.
24. Angeletti S., et al. Expression and localization of StarD7 in trophoblast cells. Placenta 2008, 29:396-404.
25. Horibata Y., Sugimoto H. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. J. Biol. Chem. 2010, 285:7358-7365.
26. Olayioye M., et al. The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Res. 2004, 64:3538-3544.
27. Olayioye M.A., et al. StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein. J. Biol. Chem. 2005, 280:27436-27442.
28. Roderick S.L., et al. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat. Struct. Biol. 2002, 9:507-511. PMID: 12055623 [PubMed - indexed for MEDLINE].
29. Kamp H.H., et al. Specificity of the phosphatidylcholine exchange protein from bovine liver. Biochemistry 1977, 16:1310-1316.
30. de Brouwer A.P., et al. The binding of phosphatidylcholine to the phosphatidylcholine transfer protein: affinity and role in folding. Chem. Phys. Lipids. 2001, 112:109-119.
31. Kasurinen J., et al. Affinity of phosphatidylcholine molecular species for the bovine phosphatidylcholine and phosphatidylinositol transfer proteins. Properties of the sn-1 and sn-2 acyl binding sites. Biochemistry 1990, 29:8548-8554.
32. Cohen D.E. Hepatocellular transport and secretion of biliary lipids. Curr. Opin. Lipidol. 1999, 10:295-302.
33. LaMorte W.W., et al. Determinants of the selection of phosphatidylcholine molecular species for secretion into bile in the rat. Hepatology 1998, 28:631-637.
34. van Helvoort A., et al. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11501-11506.
35. Wu M.K., et al. Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mice. J. Lipid Res. 2005, 46:422-431.
36. Wu M.K., Cohen D.E. Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice. Am. J. Physiol. Gastrointest Liver Physiol. 2005, 289:G456-G461.
37. Wu M.K., Cohen D.E. Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins. Am. J. Physiol. Gastrointest Liver Physiol. 2005, 289:G1067-G1074.
38. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
39. Pan H.J., et al. A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein. FEBS Lett. 2006, 580:5953-5958.
40. Dolley G., et al. Influences of the phosphatidylcholine transfer protein gene variants on the LDL peak particle size. Atherosclerosis 2007, 195:297-302.
41. Leiter E.H., et al. NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes 1998, 47:1287-1295.
42. Watkins S.M., et al. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 2002, 43:1809-1817.
43. Chahil T.J., Ginsberg H.N. Diabetic dyslipidemia. Endocrinol. Metab. Clin. North Am. 2006, 35:491-510.
44. Teerlink T., et al. Tissue distribution and subcellular localization of phosphatidylcholine transfer protein in rats as determined by radioimmunoassay. Biochim. Biophys. Acta 1982, 713:61-67.
45. Wei J., et al. Thioesterase superfamily member 2 (Them2)/acyl-CoA thioesterase 13 (Acot13): A homotetrameric hotdog fold thioesterase with selectivity for long chain fatty acyl-CoAs. Biochem. J. 2009, 421:311-322.
46. de Brouwer A.P., et al. Clofibrate-induced relocation of phosphatidylcholine transfer protein to mitochondria in endothelial cells. Exp. Cell Res. 2002, 274:100-111.
47. Kanno K., et al. Interacting proteins dictate function of the minimal START domain phosphatidylcholine transfer protein/StarD2. J. Biol. Chem. 2007, 282:30728-30736.
48. Cao J., et al. The mechanisms of human hotdog-fold Thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis. Biochemistry 2009, 48:1293-1304.
49. Machado A.F., et al. Pax3 and the splotch mutations: structure, function, and relationship to teratogenesis, including gene-chemical interactions. Curr. Pharm. Des. 2001, 7:751-785.
50. Mandard S., et al. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol. Life Sci. 2004, 61:393-416.
51. Wu M.K., et al. Cloning and gene structure of rat phosphatidylcholine transfer protein. Pctp. Gene 1999, 235:111-120.
52. Rakhshandehroo M., et al. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res. 2007, 2007:26839.
53. Kang H.W., et al. Regulatory role for phosphatidylcholine transfer protein/StarD2 in the metabolic response to peroxisome proliferator activated receptor alpha (PPARα). Biochim. Biophys. Acta 2010, 1801:496-502.
54. Chu R., et al. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 2004, 24:6288-6297.
55. de Brouwer, A.P. (2002) Functional studies on the phosphatidylcholine transfer protein. 176, Utrecht University.
56. Rhee J., et al. Partnership of PGC-1alpha and HNF4alpha in the regulation of lipoprotein metabolism. J. Biol. Chem. 2006, 281:14683-14690.
57. Gautier-Stein A., et al. Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J. Biol. Chem. 2006, 281:31268-31278.
58. Chakravarthy M.V., et al. New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005, 1:309-322.
59. Miller W.L. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim. Biophys. Acta 2007, 1771:663-676.
60. Coleman R.A., et al. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?. J. Nutr. 2002, 132:2123-2126.
61. Yuan X., et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One 2009, 4:e5609.
62. Savage D.B., et al. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 2007, 87:507-520.
63. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem. Soc. Trans. 2003, 31:1120-1124.
64. Persad S., et al. Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol. Cell. Biochem. 1998, 186:99-106.
65. Goni F.M., et al. Phase diagrams of lipid mixtures relevant to the study of membrane rafts. Biochim. Biophys. Acta 2008, 1781:665-684.
66. Niu S.L., Litman B.J. Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition. Biophys. J. 2002, 83:3408-3415.
67. Guillou H., et al. Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice. Lipids 2002, 37:981-989.
68. Tang C., et al. Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element. J. Lipid Res. 2003, 44:686-695.
69. Wheelock C.E., et al. Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics 2007, 3:137-145.
70. Buckingham M., Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 2007, 23:645-673.
71. Wagle N., et al. Small-molecule inhibitors of phosphatidylcholine transfer protein/StarD2 identified by high-throughput screening. Anal. Biochem. 2008, 383:85-92.